Aspira Women’s Health Inc (AWH) vs. Its Peers: A Comparison

VLD Stock

Additionally, the 36-month beta value for AWH is 1.51. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

The public float for AWH is 7.74M and currently, short sellers hold a 3.08% ratio of that float. The average trading volume of AWH on July 01, 2024 was 60.62K shares.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

AWH) stock’s latest price update

The stock price of Aspira Women’s Health Inc (NASDAQ: AWH) has jumped by 13.74 compared to previous close of 1.31. Despite this, the company has seen a fall of -9.70% in its stock price over the last five trading days. globenewswire.com reported 2024-06-13 that Monthly OvaSuiteSM  product volume grew by more than 26% in May compared to January Reimbursement momentum continued with expanded Anthem and Medicaid coverage for OvaSuite Cash used in operations guidance for 2024 expected to be lowered AUSTIN, Texas, June 13, 2024 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira” or the “Company”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on the development of gynecologic disease diagnostic tools, today provided interim commercial and operational updates for the second quarter of 2024. Product volume continued its sustained monthly gains, growing by more than 26% in May 2024 compared to January 2024.

AWH’s Market Performance

AWH’s stock has fallen by -9.70% in the past week, with a monthly drop of -31.02% and a quarterly drop of -51.94%. The volatility ratio for the week is 22.45% while the volatility levels for the last 30 days are 15.48% for Aspira Women’s Health Inc The simple moving average for the past 20 days is -20.84% for AWH’s stock, with a -60.75% simple moving average for the past 200 days.

Analysts’ Opinion of AWH

Many brokerage firms have already submitted their reports for AWH stocks, with Cantor Fitzgerald repeating the rating for AWH by listing it as a “Overweight.” The predicted price for AWH in the upcoming period, according to Cantor Fitzgerald is $4 based on the research report published on January 12, 2022 of the previous year 2022.

Truist, on the other hand, stated in their research note that they expect to see AWH reach a price target of $12. The rating they have provided for AWH stocks is “Buy” according to the report published on March 29th, 2021.

Cantor Fitzgerald gave a rating of “Overweight” to AWH, setting the target price at $10 in the report published on January 29th of the previous year.

AWH Trading at -41.36% from the 50-Day Moving Average

After a stumble in the market that brought AWH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.93% of loss for the given period.

Volatility was left at 15.48%, however, over the last 30 days, the volatility rate increased by 22.45%, as shares sank -30.70% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -57.31% lower at present.

During the last 5 trading sessions, AWH fell by -9.70%, which changed the moving average for the period of 200-days by -70.02% in comparison to the 20-day moving average, which settled at $1.8492. In addition, Aspira Women’s Health Inc saw -63.48% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at AWH starting from Sandford Nicole, who purchase 9,493 shares at the price of $2.42 back on May 31 ’24. After this action, Sandford Nicole now owns 70,596 shares of Aspira Women’s Health Inc, valued at $22,973 using the latest closing price.

Sandford Nicole, the President & CEO of Aspira Women’s Health Inc, purchase 5,000 shares at $3.36 during a trade that took place back on Dec 06 ’23, which means that Sandford Nicole is holding 58,703 shares at $16,800 based on the most recent closing price.

Stock Fundamentals for AWH

Current profitability levels for the company are sitting at:

  • -1.92 for the present operating margin
  • 0.59 for the gross margin

The net margin for Aspira Women’s Health Inc stands at -1.64. The total capital return value is set at -9.24. Equity return is now at value -701.30, with -158.00 for asset returns.

Based on Aspira Women’s Health Inc (AWH), the company’s capital structure generated 2.63 points at debt to capital in total, while cash flow to debt ratio is standing at -6.64. The debt to equity ratio resting at -1.61. The interest coverage ratio of the stock is 557.48.

Currently, EBITDA for the company is -18.65 million with net debt to EBITDA at 0.04. When we switch over and look at the enterprise to sales, we see a ratio of 1.98. The receivables turnover for the company is 5.87for trailing twelve months and the total asset turnover is 1.26. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.16.

Conclusion

In conclusion, Aspira Women’s Health Inc (AWH) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts